Ryan Specialty Group (RYAN) reported $751.21 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 13.2%. EPS of $0.45 for the same period compares to $0.45 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $777.88 million, representing a surprise of -3.43%. The company delivered an EPS surprise of -9.4%, with the consensus EPS estimate being $0.50.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Ryan Specialty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Ryan Specialty here>>>
Shares of Ryan Specialty have returned -14.2% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Oct-01 | |
| Jul-30 | |
| Jul-29 | |
| Jul-06 | |
| Jul-02 | |
| Jun-24 | |
| Jun-08 | |
| May-28 | |
| May-26 | |
| May-01 | |
| May-01 | |
| Apr-30 | |
| Apr-29 | |
| Apr-06 | |
| Mar-11 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite